Drug intelligence / Profile preview

artemisia annua pollen skin prick solution

Development stage
Phase 3
Lead developer
Wolwo Biotech
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Percutaneous
01

Overview

Artemisia annua pollen skin prick solution is a diagnostic allergen extract developed by Zhejiang Wolwo Bio-Pharmaceutical for the identification of sensitization to sweet wormwood (*Artemisia annua*) pollen. It is used in skin prick testing, a common diagnostic procedure for allergic diseases such as allergic rhinitis and allergic conjunctivitis. When applied percutaneously, the solution introduces pollen allergens into the skin; in individuals with specific IgE antibodies to these allergens, the extract cross-links IgE on the surface of mast cells, triggering degranulation and the release of inflammatory mediators. This results in a localized wheal-and-flare reaction, the size of which indicates the degree of sensitization. The product has been evaluated in Phase III clinical trials in China (e.g., CTR20200810) to establish its safety and diagnostic performance (sensitivity and specificity) alongside other common allergen extracts.

Other names
Artemisia annua pollen extract
02

Targets

B-cell receptor specific for Artemisia annua allergensArtemisia annua-specific T-cell receptor (Artemisia-specific TCR)IgE (Immunoglobulin E)

Beyond the preview

Go deeper on artemisia annua pollen skin prick solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on artemisia annua pollen skin prick solution.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call